EphA1, the first identified Eph family member, is physiologically expressed in epithelial tissues, and its pathological overexpression has been reported in a variety of tumors, including gastric cancer [15], liver cancer [16], prostate cancer [17], and esophageal squamous cell carcinoma [18]. Here, EPHA1 is linked to prostate cancer.